Vivakor (US:VIVK) Benzinga·2025-10-16 14:00Market Overview - U.S. stocks experienced an upward trend, with the Dow Jones index increasing by over 100 points, closing at 46,412.27, a rise of 0.34% [1] - The NASDAQ rose by 0.73% to 22,834.55, and the S&P 500 gained 0.41% to 6,698.54 [1] - Communication services sector saw a notable increase of 1.4%, while financial stocks declined by 0.7% [1] Company Earnings - Charles Schwab Corporation reported third-quarter adjusted earnings per share of $1.31, reflecting a 70% year-over-year increase, surpassing the analyst consensus estimate of $1.25 [2] - The company's quarterly sales reached $6.135 billion, a 27% year-over-year growth, exceeding the expected $6.009 billion [2] Commodity Market - Oil prices increased by 0.2% to $58.38, while gold rose by 1.6% to $4,269.40 [5] - Silver saw a 2.1% increase to $52.455, whereas copper fell by 1% to $4.9660 [5] Asian Market Performance - Asian markets closed predominantly higher, with Japan's Nikkei 225 surging by 1.27% and India's BSE Sensex rising by 1.04% [7] - Hong Kong's Hang Seng index experienced a slight decline of 0.09%, while China's Shanghai Composite rose by 0.10% [7] Stock Movements - Praxis Precision Medicines Inc shares surged by 202% to $173.05 following positive Phase 3 trial results [9] - Vivakor Inc shares increased by 82% to $0.54 after announcing a $40 million credit facility [9] - Mira Pharmaceuticals Inc shares rose by 63% to $2.15 due to new preclinical data [9] - UTime Ltd shares plummeted by 83% to $0.20 after a $25 million registered direct offering announcement [9] - Theriva Biologics Inc shares fell by 49% to $0.43 after a $4 million warrant inducement agreement [9] - Hyperfine Inc shares decreased by 41% to $1.30 following a $17.5 million public offering announcement [9] Economic Indicators - The Philadelphia Fed Manufacturing Index dropped to a six-month low of -12.8 in October, down from 23.2 in the previous month, missing market estimates of 10 [10]